A novel homozygous mutation in RASGRP1 that predisposes to immune dysregulation and immunodeficiency associated with uncontrolled Epstein-Barr virus-induced B cell proliferation

Copyright © 2023 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 257(2023) vom: 22. Dez., Seite 109813
1. Verfasser: Mansour, Rana (VerfasserIn)
Weitere Verfasser: El-Orfali, Youmna, Saidu, Adam, Al-Kalamouni, Habib, Mardirossian, Hagop, Hanna-Wakim, Rima, Abboud, Miguel, Massaad, Michel J
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2023
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Case Reports Journal Article Research Support, Non-U.S. Gov't Epstein-Bar virus infections Immune dysregulation Immunodeficiency RASGRP1 deficiency T cell function DNA-Binding Proteins Guanine Nucleotide Exchange Factors RASGRP1 protein, human
LEADER 01000caa a22002652 4500
001 NLM363904247
003 DE-627
005 20240410232244.0
007 cr uuu---uuuuu
008 231226s2023 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.clim.2023.109813  |2 doi 
028 5 2 |a pubmed24n1371.xml 
035 |a (DE-627)NLM363904247 
035 |a (NLM)37898412 
035 |a (PII)S1521-6616(23)00576-4 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Mansour, Rana  |e verfasserin  |4 aut 
245 1 2 |a A novel homozygous mutation in RASGRP1 that predisposes to immune dysregulation and immunodeficiency associated with uncontrolled Epstein-Barr virus-induced B cell proliferation 
264 1 |c 2023 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 03.01.2024 
500 |a Date Revised 10.04.2024 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a Copyright © 2023 Elsevier Inc. All rights reserved. 
520 |a BACKGROUND: RASGRP1-deficiency results in an immune dysregulation and immunodeficiency that manifest as autoimmunity, lymphoproliferation, lymphopenia, defective T cell function, and increased incidence of Epstein-Bar Virus infections and lymphomas 
520 |a OBJECTIVE: To investigate the mechanism of autoimmune hemolytic anemia and infections in a male patient of consanguineous parents from Lebanon 
520 |a METHODS: Genetic diagnosis was obtained using next generation and Sanger sequencing. Protein expression and phosphorylation were determined by immunoblotting. T and B cell development and function were studied by flow cytometry. Cytokine and immunoglobulin secretions were quantified by enzyme-linked immunosorbent assay 
520 |a RESULTS: The patient suffered from severe lymphopenia especially affecting the T cell compartment. Genetic analysis revealed a homozygous insertion of adenine at position 1396_1397 in RASGRP1 that abolished protein expression and downstream Ras signaling. T cells from the patient showed severe activation defects resulting in uncontrolled Epstein-Bar Virus-induced B cell proliferation. B cells from the patient were normal 
520 |a CONCLUSION: This report expands the spectrum of mutations in patients with RasGRP1 deficiency, and provides evidence for the important role RasGRP1 plays in the ability of T cells to control Epstein-Bar Virus-induced B cell proliferation 
520 |a CLINICAL IMPLICATIONS: Following diagnosis, the patient will be maintained on oral valganciclovir and monitored regularly for Epstein-Bar Virus infections to avoid the development of Epstein-Bar Virus- induced B cell lymphoma. He is also candidate for hematopoietic stem cell transplantation 
650 4 |a Case Reports 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 4 |a Epstein-Bar virus infections 
650 4 |a Immune dysregulation 
650 4 |a Immunodeficiency 
650 4 |a RASGRP1 deficiency 
650 4 |a T cell function 
650 7 |a DNA-Binding Proteins  |2 NLM 
650 7 |a Guanine Nucleotide Exchange Factors  |2 NLM 
650 7 |a RASGRP1 protein, human  |2 NLM 
700 1 |a El-Orfali, Youmna  |e verfasserin  |4 aut 
700 1 |a Saidu, Adam  |e verfasserin  |4 aut 
700 1 |a Al-Kalamouni, Habib  |e verfasserin  |4 aut 
700 1 |a Mardirossian, Hagop  |e verfasserin  |4 aut 
700 1 |a Hanna-Wakim, Rima  |e verfasserin  |4 aut 
700 1 |a Abboud, Miguel  |e verfasserin  |4 aut 
700 1 |a Massaad, Michel J  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 257(2023) vom: 22. Dez., Seite 109813  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:257  |g year:2023  |g day:22  |g month:12  |g pages:109813 
856 4 0 |u http://dx.doi.org/10.1016/j.clim.2023.109813  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 257  |j 2023  |b 22  |c 12  |h 109813